FAR2 expression in human patients. A: FAR2 is upregulated in the glomeruli isolated from chronic kidney disease (CKD) patients relative to healthy living donor samples. B: FAR2 is upregulated in the glomeruli isolated from diabetic nephropathy (DN), focal segmental glomerulosclerosis (FSGS), IgA nephropathy (IgA), minimal change disease (MCD), membranous glomerulonephropathy (MGN), and systemic lupus erythematosus nephritis (SLE). Significant P values are denoted by *P < 0.05, **P < 0.005, ***P < 0.0005, and ****P < 0.00001 relative to healthy living donor by a one-tailed Student’s t-test on nonlog-transformed expression data.